SCR-LIP-000686 · Claim · machine-readable JSON →
In people with chronic venous insufficiency, concomitant lipedema is associated with smaller quality-of-life gains after endovenous ablation, and lipedema symptoms persist after treatment.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Lipedema symptoms are not influenced by endothermal ablation in patients with varicose veins — Reyes Valdivia et al. (2026) ✓ verified — consistent · cohort · 2026 · reading confidence: high
“Embora a ETA melhore significativamente a QoL em pacientes com IVC, aqueles com lipedema concomitante apresentam ganhos menores e maior taxa de parestesia pós-operatória.”
Patients with lipedema had worse baseline CIVIQ-20 (61.0 vs 46.0, p=0.001) and smaller improvement after endothermal ablation (4.0 vs 13.5 points, p=0.012); lipedema independently predicted worse postoperative CIVIQ-20 and its symptoms were unchanged; more postoperative paresthesia.
Cohort comparing patients with chronic venous insufficiency with versus without concomitant lipedema undergoing endovenous ablation, directly addressing how lipedema coexists with and modifies venous disease outcomes; multivariate analysis
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000018